Jinhe Biotechnology(SZ:002688) Xin Lang Cai Jing·2026-01-26 05:25Group 1 - The core viewpoint of the news is that Jinhe Biology's stock has seen a significant increase of 5.16%, reaching 6.72 CNY per share, with a trading volume of 205 million CNY and a turnover rate of 4.22%, resulting in a total market capitalization of 5.185 billion CNY [1] - Jinhe Biology, established on March 14, 1990, and listed on July 13, 2012, is located in Inner Mongolia and specializes in the production, sales, research, and services of animal health products [1] - The company's main business revenue composition includes: veterinary chemical drugs 61.83%, starch and related products 19.76%, veterinary vaccines 11.12%, environmental services 4.97%, others 2.15%, and drug feed additives 0.18% [1] Group 2 - From the perspective of major circulating shareholders, Guotai Fund's ETF, Guotai Zhongzheng Animal Husbandry ETF (159865), increased its holdings by 4.3964 million shares, totaling 12.0555 million shares, which accounts for 1.61% of the circulating shares [2] - The Guotai Zhongzheng Animal Husbandry ETF has a current scale of 5.949 billion CNY, with a year-to-date loss of 0.41%, ranking 5172 out of 5580 in its category; over the past year, it has achieved a return of 15.98%, ranking 3639 out of 4271; since its inception, it has a loss of 37.07% [2] Group 3 - The fund manager of Guotai Zhongzheng Animal Husbandry ETF is Liang Xing, who has a cumulative tenure of 9 years and 235 days, with the fund's total asset scale at 29.35 billion CNY [3] - During Liang Xing's tenure, the best fund return was 1112.34%, while the worst return was -54.39% [3]